Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medirom Healthcare Technologies (MRM) Common Equity (2019 - 2025)

Historic Common Equity for Medirom Healthcare Technologies (MRM) over the last 7 years, with Q2 2025 value amounting to $2.1 million.

  • Medirom Healthcare Technologies' Common Equity changed N/A to $2.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $2.1 million, marking a year-over-year change of. This contributed to the annual value of $6.5 million for FY2024, which is 34476.74% up from last year.
  • Latest data reveals that Medirom Healthcare Technologies reported Common Equity of $2.1 million as of Q2 2025.
  • In the past 5 years, Medirom Healthcare Technologies' Common Equity ranged from a high of $6.5 million in Q4 2024 and a low of -$1.8 million during Q4 2021
  • For the 5-year period, Medirom Healthcare Technologies' Common Equity averaged around $1.6 million, with its median value being $1.7 million (2023).
  • Per our database at Business Quant, Medirom Healthcare Technologies' Common Equity tumbled by 13898.55% in 2021 and then surged by 44761.82% in 2023.
  • Over the past 5 years, Medirom Healthcare Technologies' Common Equity (Quarter) stood at -$1.8 million in 2021, then surged by 77.07% to -$420296.4 in 2022, then surged by 447.62% to $1.5 million in 2023, then skyrocketed by 344.77% to $6.5 million in 2024, then plummeted by 68.31% to $2.1 million in 2025.
  • Its Common Equity stands at $2.1 million for Q2 2025, versus $6.5 million for Q4 2024 and $1.5 million for Q4 2023.